Home health and hospice vertical
Home health agency acquisitions: hospice vs home care.
Home health agency acquisitions keep getting filed under the same sourcing playbook as assisted living communities and non-medical home care, mostly because they all sit under the broad "senior care" heading in a deal deck. That grouping breaks down as soon as you try to actually source one. Home health is Medicare-certified, physician-ordered, skilled care, closer in regulatory terms to hospice than to a companion-care franchise, and it is sourced through a completely different referral network.
This post covers what makes home health agency acquisitions distinct from hospice and from the broader senior care category, why certificate-of-need laws change the buy-side maths, and where the real off-market conversations come from.
What is a home health agency acquisition, exactly?
A home health agency acquisition is the purchase of a Medicare-certified provider of skilled nursing, physical therapy, and related clinical services delivered in a patient's home, under a physician's order, rather than in a facility.
That certification requirement is the key detail. Unlike the non-medical home care and assisted living businesses we cover in our senior care acquisitions guide, a home health agency bills Medicare Part A directly for clinical services, operates under federal conditions of participation, and is subject to state health department survey. It is a licensed healthcare provider, not a personal care or companionship service, and buyers who treat it like the latter miss most of what actually drives the deal.
How is home health different from hospice, and does it matter for sourcing?
Home health and hospice are both Medicare-certified, physician-order-driven services, but they serve different patients under different benefits, and that changes who refers into each one. Home health serves patients recovering from an illness, injury, or hospitalisation with the goal of improvement or stabilisation. Hospice serves patients with a terminal prognosis under the Medicare hospice benefit, with a goal of comfort rather than recovery.
The practical sourcing implication is that the two businesses often share an owner and a back office, which is why many roll-ups acquire both under one platform, but they do not share a referral base. Home health leans on hospital discharge planners and post-acute physician relationships. Hospice leans more heavily on oncology practices, palliative care teams, and long-term care facilities. A buyer building a target list for one cannot simply reuse the list for the other.
How do home health and hospice compare with senior care and assisted living deals?
The comparison matters because the three categories get lumped together in most deal decks, and treating home health agency acquisitions as interchangeable with the other two produces the wrong sourcing approach.
| Factor | Home health agency | Hospice | Assisted living / non-medical home care |
|---|---|---|---|
| Primary payer | Medicare Part A | Medicare hospice benefit | Private pay, long-term care insurance |
| Physician order required | Yes | Yes | No |
| Regulatory barrier to entry | Medicare certification, CON in some states | Medicare certification, CON in most states | State licensing, generally lower barrier |
| Typical referral source | Hospital discharge planners, physicians | Oncology, palliative care, long-term care facilities | Word of mouth, elder law attorneys, senior placement agencies |
| Typical seller profile | Clinician-founder or regional operator | Clinician-founder, often faith-affiliated legacy operators | Family-owned, often first-generation operator |
| Deal driver | Census growth, star ratings, staffing | Average daily census, length of stay | Occupancy, staffing ratios, real estate |
Why do certificate-of-need laws change how you source these deals?
Certificate-of-need (CON) laws restrict the issuance of new home health and hospice licences in many US states, which means acquiring an existing licensed agency is often the only practical way to enter or expand in that state. That single fact reshapes the entire buy-side calculation.
In a CON state, the licence itself carries real value independent of the agency's current performance, and owners of licensed agencies are aware of it. It also means the acquisition target universe in a CON state is fixed and known, which is exactly the kind of closed, mappable market that rewards a direct, systematic outreach programme over waiting for a broker to bring you a deal. Buyers who identify every licensed operator in a target state and reach them directly, before an agency is formally listed, are working from a real information advantage.
Where do the best off-market home health and hospice conversations actually come from?
They come from direct outreach into a mapped list of licensed operators, not from the general small-business broker channel that works for most other service verticals. Because these are healthcare businesses with a defined owner (often a clinician-operator, sometimes a second-generation family owner), a respectful, well-timed direct approach tends to outperform waiting for an inbound listing.
That pattern shows up in our own outreach data too. Across nearly 1.6 million recent cold outreach sends that Danish Lead Co. manages for PE-backed platforms and M&A advisors, healthcare-adjacent categories such as hospitals and health care and medical practice consistently rank among the top-responding industries. Owners with a clinical background tend to engage with a direct, specific, well-researched message rather than a generic acquisition teaser, which matters for a category where the seller usually has a clinical rather than a purely commercial background.
There is also a demographic tailwind behind the supply of these deals. CNBC has reported that roughly half of US small-business owners are 55 or older, most without a documented succession plan, and clinician-founders of home health and hospice agencies are no exception. Many built a single-state or regional agency over a decade or two and have never been approached by a serious buyer.
What should a buyer screen for before making an offer?
Screening a home health or hospice target starts with the same fundamentals covered in our general acquisition target screening framework, plus a few category-specific items: recent state survey and deficiency history, CMS star rating trend, payer mix and average daily census trend, and staffing turnover among clinical nurses and aides. A licence in good standing with a declining census or a poor survey history is a materially different deal than the same licence attached to a growing, well-run agency, even at the same headline revenue.
Conclusion
Treating home health agency acquisitions as a sub-category of senior care, or as interchangeable with hospice, pushes buyers toward the wrong target list and the wrong outreach channel. The certification requirements, the certificate-of-need dynamics, and the referral network are specific to home health, and a sourcing programme built around those specifics will consistently find agencies that a generic senior care search misses.
Frequently asked questions
Are home health and hospice acquisitions regulated the same way?
Both require Medicare certification and are subject to federal conditions of participation, and both are covered by certificate-of-need laws in many states. The clinical services, patient population, and referral sources differ, which is why sourcing and diligence need to treat them as related but distinct categories.
Why do certificate-of-need laws matter so much for these deals?
In a CON state, the number of licensed agencies is capped, so a buyer generally cannot simply open a new location. Acquiring an existing licence is the primary route to entering or expanding in that market, which makes the licensed-operator universe finite, mappable, and worth sourcing directly rather than waiting for listings.
Can one platform own both a home health agency and a hospice?
Yes, and many roll-ups do exactly that, sharing back-office, compliance, and administrative infrastructure across both licences while keeping clinical operations and referral relationships separate, since the two businesses serve different patients through different referral sources.
How is sourcing a home health agency different from sourcing an assisted living community?
Home health sourcing runs through hospital discharge planners and physician relationships and depends on Medicare certification status. Assisted living and non-medical home care sourcing runs through word of mouth, elder law attorneys, and senior placement agencies, with a lower regulatory barrier to entry. See our senior care acquisitions guide for that side of the comparison.
What is the typical seller profile in a home health agency acquisition?
Most independent home health and hospice agencies are still owned by their clinician-founder or a small group of clinical partners who built the agency over ten to twenty years. Many have never had a formal conversation with a private equity buyer, which is part of why direct outreach performs well in this category.
How does DealSource Systems source home health and hospice acquisitions?
We build direct outreach programmes that map the licensed-operator universe in a target state and reach owners before a formal process begins, using the same systematic approach across healthcare verticals described in our healthcare deal origination guide. See our solutions for PE buyers and M&A advisors, or how our origination programmes work.